Experienced in producing high potency products on a large scale:
- Batch – fast, simple, proof of concept
- Fed-batch – high cell density, cost-effective
- Continuous – smaller footprint, higher volumetric productivity, reduced capital, strain adaptation
![](https://www.ingenza.com/wp-content/themes/ingenza2022/images/modes-sup-1.jpg)
— Professor George Hanna, Director, NIHR Diagnostic Evidence Co-operative and Head of Surgery, St. Mary’s Hospital, Paddington, London